AR049879A1 - Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos - Google Patents

Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos

Info

Publication number
AR049879A1
AR049879A1 ARP050101320A ARP050101320A AR049879A1 AR 049879 A1 AR049879 A1 AR 049879A1 AR P050101320 A ARP050101320 A AR P050101320A AR P050101320 A ARP050101320 A AR P050101320A AR 049879 A1 AR049879 A1 AR 049879A1
Authority
AR
Argentina
Prior art keywords
bis
diphenylphosphino
alkyl
substituted
benzene
Prior art date
Application number
ARP050101320A
Other languages
English (en)
Original Assignee
Solvias Ag
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34964957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049879(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvias Ag, Merck & Co Inc filed Critical Solvias Ag
Publication of AR049879A1 publication Critical patent/AR049879A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se refiere a un procedimiento para la preparacion eficiente de derivados de beta aminio ácido enantioméricamente enriquecido donde el grupo amino no está protegido. Los productos derivados beta aminoácidos quirales son utiles en la síntesis asimétrica de moléculas biologicamente activas. El procedimiento comprende una hidrogenacion enantioselectiva de una amina no protegida proquiral de ácido acrílico beta amino o el derivado en la presencia del precursor rodio metal complejado con un ligando quiral mono- o bisfosfina. Reivindicacion 1: Un procedimiento para la preparacion de un compuesto de formula estructural (1), enantioméricamente enriquecido en el átomo marcado con un *; donde Z es OR2, SR2, o NR2R3; R1 es alquil C1-8, aril, heteroaril, aril-alquilC1-2, o heteroaril-alquilC1-2; E2 y R3 son cada uno independientemente hidrogeno, alquil C1-8, aril, o aril-alquilC1-2; o R2 y R3 junto con el átomo de nitrogeno al cual ellos están unidos para formar un sistema heterocíclico anular de 4- a 7- miembros que opcionalmente contiene un heteroátomo adicional seleccionado entre O, S, N, NH, y N alquilC1-4, dicho anillo heterocíclico puede estar no sustituido o sustituido con de uno a tres sustituyentes independientemente seleccionados entre oxo, hidroxi, halogeno, alcoxi C1-4, y alquil C1-4 donde el alquil y el alcoxi están no sustituidos o sustituidos con de uno a cinco átomos de fluor; y dicho sistema anular heterocíclico está opcionalmente fusionado con un sistema anular carbocíclico aromático o saturado de 5- a 6- miembros o sistema anular heterocíclico aromático o saturado de 5- a 6- miembros que contiene de uno a tres heteroátomos seleccionados entre O, S, N, NH, y N alquilC1-4, dicho sistema anular fusionado puede estar no sustituido o sustituido con de uno a cuatro sustituyentes seleccionados entre hidroxi, amino, fluor, alquil C1-4, y alcoxi C1-4, donde el alquil y el alcoxi no están sustituidos o están sustituidos con de uno a cinco átomos de fluor; que comprenden el paso de la hidrogenacion en la presencia de hidrogeno gas de una enamina proquiral de formula estructural (2), en un solventes adecuado en la presencia del precursor metal sodio complejado a un ligando quiral mono- o bisfosfina; con las condiciones de que: a) el ligando bisfosfina quiral no es un ligando ferrocenil bisfosfina de formula estructural (3), donde R4 es alquil C1-4 o aril; R5 y R6 son cada uno independientemente alquil C1-6, cicloalquil C5-12, o aril; y R7 es alquilC1-4 o fenil no sustituido; y que b) el ligando quiral bisfosfina no es un ligando seleccionado entre el grupo consistente en: 1,2-bis(anisilfenilfosfino)etano; 1,2-bis(alquilmetilfosfino)etano; 2,3- bis(difenilfosfino)butano; 1,2-bis(difenilfosfino)propano; 2,3-bis(difenilfosfino)-5-norborneno; 2,3-O-isopropiliden-2,3-dihidroxi-1,4-bis-(difenilfosfino)butano; 1-ciclohexil-1,2-bis(difenilfosfino)etano; 1-sustituido-3,4- bis(difenilfosfino)pirrolidina; 2,4-bis(difenilfosfino)pentano; 1,2-bis(fosfolano sustituido)benceno; 1,2-bis(fosfolano sustituido)etano; 1-(fosfolano sustituido)-2-(difenilfosfino)benceno; 1-(bis(3,5-dimetilfenil)fosfino)-2-(fosfolano sustituido)benceno; 1-(fosfolano sustituido)-2-(bis(3,5-di(t-butil)-4-metoxifenil)fosfino)benceno; 1-(fosfolano sustituido)-2-(di-naftalen-1-il-fosfino)benceno; 2,2'-bis(difenilfosfino)-1,1'-binaftil; 2,2'-bis(di-p-tolilfosfino)-1,1'-binaftil; 2,2'- bis(di(3,5-dimetilfenil)fosfino)-1,1'-binaftil; 2,2'-bis(difenilfosfino)-6,6'-dimetil-1,1'-bifenil; ((5,6)(5',6')-bis(metilenedioxi)bifenil-2,2'-diil)(bisdifenilfosfina); ((5,6)(5',6')-bis(metilenedioxi)bifenil-2,2'-diil)(bis(3,5- dimetilfenil)fosfina); ((5,6)(5',6')-bis(metilenedioxi)bifenil-2,2'-diil)(bis(3,5-di(t-butil)fenil)fosfina); ciclohexilanisilmetilfosfina; 1-[1',2-bis(difenilfosfino)ferrocenil]etilamina; 1-[1',2-bis(difenilfosfino)ferrocenil]etil alcohol; 2,2'- bis(difenilfosfino)-1,1'-ciclopentano; y 2,2'-bis(difenilfosfino)-1,1'-(5,5'6,6',7,7'8,8'-octahidrobinaftil.
ARP050101320A 2004-04-05 2005-04-04 Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos AR049879A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55951404P 2004-04-05 2004-04-05
US64669805P 2005-01-24 2005-01-24

Publications (1)

Publication Number Publication Date
AR049879A1 true AR049879A1 (es) 2006-09-13

Family

ID=34964957

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101320A AR049879A1 (es) 2004-04-05 2005-04-04 Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos

Country Status (8)

Country Link
US (1) US7495123B2 (es)
EP (1) EP1735269A1 (es)
JP (1) JP2007531795A (es)
AR (1) AR049879A1 (es)
AU (1) AU2005230693A1 (es)
CA (1) CA2561973A1 (es)
TW (1) TW200602293A (es)
WO (1) WO2005097733A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043515A1 (es) 2003-03-19 2005-08-03 Merck & Co Inc Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica
AR052879A1 (es) * 2005-01-24 2007-04-11 Merck & Co Inc Procedimiento para preparar derivados de beta aminoacidos quirales por hidrogenacion asimetrica
AU2006242542A1 (en) 2005-04-29 2006-11-09 Wyeth Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
WO2008031750A2 (en) * 2006-09-15 2008-03-20 F. Hoffmann-La Roche Ag Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine
JP2011519340A (ja) * 2007-10-30 2011-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換アルカン酸調製のためのエナンチオ選択的プロセスこの米国特許正規出願は、２００７年１０月３０日に提出された米国特許仮出願第６１／００１，００４号、及び２００８年２月２９日に提出された米国特許仮出願第６１／０６７，８４２号の権利を主張する。
US8334385B2 (en) * 2007-11-02 2012-12-18 Glenmark Generics Limited Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
EP2223923A1 (en) 2009-02-25 2010-09-01 Esteve Química, S.A. Process for the preparation of a chiral beta aminoacid derivative and intermediates thereof
IT1395596B1 (it) 2009-06-30 2012-10-16 Dipharma Francis Srl Procedimento per la preparazione di sitagliptin
CZ303113B6 (cs) * 2010-03-16 2012-04-11 Zentiva, K.S. Zpusob prípravy sitagliptinu
WO2011135586A2 (en) 2010-04-28 2011-11-03 Sun Pharmaceutical Industries Ltd. Process for the preparation of chiral beta amino carboxamide derivatives
WO2011151443A1 (en) 2010-06-04 2011-12-08 Lek Pharmaceuticals D.D. A NOVEL SYNTHETIC APPROACH TO ß-AMINOBUTYRYL SUBSTITUTED COMPOUNDS
EP2392575A1 (en) 2010-06-04 2011-12-07 LEK Pharmaceuticals d.d. A novel synthetic approach to ß-aminobutyryl substituted compounds
EP2397141A1 (en) 2010-06-16 2011-12-21 LEK Pharmaceuticals d.d. Process for the synthesis of beta-amino acids and derivatives thereof
EP2508506A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Preparation of sitagliptin intermediates
EP2527320A1 (en) 2011-05-27 2012-11-28 LEK Pharmaceuticals d.d. Preparation of Sitagliptin Intermediates
EP2736909B1 (en) 2011-07-27 2017-03-29 Farma GRS, d.o.o. Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
WO2013065066A1 (en) 2011-11-02 2013-05-10 Cadila Healthcare Limited Processes for preparing 4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro [l,2,41-triazolo[43-a]pyrazin-7(8h)-yl]-l-(2,4,5- trifluorophenyl)butan-2-amine
EP2615080A1 (en) 2012-01-12 2013-07-17 LEK Pharmaceuticals d.d. Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof
EP2674432A1 (en) 2012-06-14 2013-12-18 LEK Pharmaceuticals d.d. New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds
CA2901591A1 (en) 2013-03-11 2014-10-09 Rutgers, The State University Of New Jersey Metallorganocatalysis for asymmetric transformations
IN2013MU00916A (es) 2013-03-20 2015-06-26 Cadila Healthcare Ltd
EP3159343B1 (en) 2015-10-22 2017-07-19 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of triazole and salt thereof
US10047094B1 (en) 2017-02-10 2018-08-14 F.I.S.—Fabbrica Italiana Sintetici S.p.A. Process for the preparation of triazole and salt thereof
US20220048917A1 (en) * 2018-12-11 2022-02-17 Council Of Scientific & Industrial Research Highly efficient process for the preparation of sitagliptin via rhodium catalyzed asymmetric hydrogenation
WO2020194337A2 (en) * 2019-03-28 2020-10-01 Council Of Scientific And Industrial Research A process for the asymmetric synthesis of sitagliptin intermediate
CN113636950B (zh) 2020-05-11 2023-01-17 浙江医药股份有限公司新昌制药厂 一种手性4-芳基-β-氨基酸衍生物的制备方法
CN114516847B (zh) * 2022-03-09 2024-01-30 台州达辰药业有限公司 一种西他列汀中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG42936A1 (en) 1992-04-02 1997-10-17 Ciba Geigy Ag Ferrocenyl diphosphines as ligands for homogeneous catalysts
EP0967015B1 (de) 1998-06-19 2005-01-12 Degussa AG Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung
EP1228034A4 (en) * 1999-11-10 2003-05-07 Penn State Res Found CHIRAL PHOSPHINES, AND COMPLEXES THEREOF WITH TRANSITIONAL METALS AND USE OF SUCH COMPLEXES IN ASYMMETRIC REACTIONS
US6258979B1 (en) 1999-11-22 2001-07-10 Henri Kagan Chiral ferrocene phosphines active in asymmetric catalysis
DE19956414A1 (de) 1999-11-24 2001-06-13 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von chiralen Aminen durch homogen katalysierte asymmetrische Hydrierung von Enaminen
AU2002216719A1 (en) 2000-11-17 2002-05-27 The Penn State Research Foundation Ortho substituted chiral phosphines and phosphinites and their use in asymmetriccatayltic reactions
DE10100971A1 (de) 2001-01-11 2002-07-18 Degussa Verfahren zur Herstellung enantiomerenangereicherter beta-Aminosäure
US6808773B2 (en) 2001-05-24 2004-10-26 Kyodo Printing Co., Ltd. Shielding base member and method of manufacturing the same
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
EP1386901B1 (en) * 2002-07-30 2015-07-01 Takasago International Corporation Method for producing an optically active beta-amino acid
AR043515A1 (es) * 2003-03-19 2005-08-03 Merck & Co Inc Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica

Also Published As

Publication number Publication date
WO2005097733A1 (en) 2005-10-20
EP1735269A1 (en) 2006-12-27
TW200602293A (en) 2006-01-16
US7495123B2 (en) 2009-02-24
JP2007531795A (ja) 2007-11-08
AU2005230693A1 (en) 2005-10-20
US20080058522A1 (en) 2008-03-06
CA2561973A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
AR049879A1 (es) Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos
AR043515A1 (es) Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica
Jerphagnon et al. Chiral monodentate phosphorus ligands for rhodium-catalyzed asymmetric hydrogenation
Reznichenko et al. Asymmetric hydroamination
Gopalaiah et al. Use of nonfunctionalized enamides and enecarbamates in asymmetric synthesis
Pelagatti et al. Transfer hydrogenation of acetophenone catalyzed by half-sandwich ruthenium (II) complexes containing amino amide ligands. Detection of the catalytic intermediates by electrospray ionization mass spectrometry
Bernsmann et al. PipPhos and MorfPhos: privileged monodentate phosphoramidite ligands for rhodium-catalyzed asymmetric hydrogenation
Xiao et al. Synthesis of a novel chiral binaphthyl phospholane and its application in the highly enantioselective hydrogenation of enamides
Bagi et al. Resolution of P-stereogenic P-heterocycles via the formation of diastereomeric molecular and coordination complexes (a review)
ES2331011T3 (es) Nuevo procedimiento para la sintesis de derivados de alfa-aminoindanos sustituidos.
Togni et al. Enantioselective synthesis of β-hydroxy-α-aminophosphonic acid precursors
Qu et al. Synthesis of Pyridyl-dihydrobenzooxaphosphole Ligands and Their Application in Asymmetric Hydrogenation of Unfunctionalized Alkenes
Mino et al. Synthesis and optical resolution of aminophosphines with axially chiral C (aryl)− N (amine) bonds for use as ligands in asymmetric catalysis
Dzięgielewski et al. Organocatalytic synthesis of optically active organophosphorus compounds
Tillu et al. One-pot three-component Kabachnik–Fields synthesis of α-aminophosphonates using H-beta zeolite catalyst
BRPI0716080B1 (pt) Process for the production of oticly active bioohanic acids (aminofosfinil)
IL177561A (en) Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
Rachwalski et al. Highly enantioselective asymmetric direct aldol reaction catalyzed by amine-functionalized tridentate sulfinyl ligands
ES2583752T3 (es) Compuesto quiral de fósforo
DK1670792T3 (da) Fremgangsmåde til fremstilling af chirale propionsyrederivater
Phosphines 1.9 The use of New Phosphines as Powerful Tools in Asymmetric Synthesis of Biologically Active Compounds
Guo et al. Recent advances in catalytic asymmetric hydrogenation: Renaissance of the monodentate phosphorus ligands
ES2348060T3 (es) Fosfinas quirales de fósforo, basadas en metalocenos.
WO2006026489A1 (en) Novel diazaphospholane ligands for asymmetric catalysis
ES2362289T3 (es) Proceso para la hidrogenación asimétrica catalizada por metales de transición de derivados del ácido acrílico y nuevo sistema catalítico para el catalizado de metal de transición asimétrica.

Legal Events

Date Code Title Description
FB Suspension of granting procedure